Coronary Calcium Remains an Effective Filter for Invasive Angiography  by Budoff, Matthew J.
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August 10, 2010:611–5oronary Calcification
nd Coronary Artery Disease
ottlieb et al. (1) report computed tomography (CT) calcium
cores in 291 patients (73% male) being referred for coronary
ngiography. The majority (95%) had either intermediate or high
re-test probability of coronary disease, and 42 (19.6%) had
resented as emergencies with unstable angina. The authors report
surprisingly low sensitivity of only 45% for a calcium score of 0
o predict the absence of 50% lesions, that led your editorialist
2) to question the incremental value of calcium scoring for
iagnosing coronary artery disease (CAD). Yet, as stated in the
ditorial, the value of any diagnostic test is critically dependent on
he population in which it is applied. Calcium scoring has been
ecommended as a useful rule-out in patients with a low proba-
ility of CAD, based on meta-analysis that yields sensitivity
stimates in excess of 90%, higher than most other methods of
oninvasive testing (3). The patient population in the Gottlieb
t al. (1) study is quite inappropriate for challenging this recom-
endation based on their high pre-test probability, their pre-
election for cardiac catheterization, their male predominance, and
heir high rates of unstable presentation. It is unclear what added
alue a calcium score could possibly make to the diagnosis of CAD
n this group. Nevertheless, among the Gottlieb et al. (1) popula-
ion, we find clues to the real value of calcium scanning for CAD
ule-out in the 8 patients with a low pre-test probability of disease
nd a zero calcium score, none of whom had angiographic CAD.
t present, we are often prepared to base diagnostic decisions in
uch patients on treadmill stress testing despite its low sensitivity
4) and negligible incremental value for risk assessment (5). It is in
his low-risk population of patients with stable chest pain and a
ow pre-test probability of CAD that calcium scoring is likely to
nd its place as a simple and safe means for disease rule-out in
linical practice.
Adam Timmis, MD
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arts and the London NHS Trust
onner Road
ondon E2 9JX
ngland
-mail: adamtimmis@mac.com
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oronary Calcium
emains an Effective
ilter for Invasive Angiography
ottlieb et al. (1) question the current guidelines in regard to
oronary calcium scoring (CCS) in symptomatic persons and
uggest their small study trumps 25 years of published literature.
oronary artery calcium (CAC) guidelines are written based on
1,000 studies, including several that were 5 to 10 times larger
han the cohort reported. Furthermore, the authors excluded 89
atients who were enrolled in CORE64 (Coronary Evaluation
sing Multi-Detector Spiral Computed Tomography Angiogra-
hy Using 64 Detectors) who had CAC 600. Imagine a paper
tating hypertension does not correlate with left ventricular hyper-
rophy, but the study inconspicuously eliminated patients who had
ignificant hypertension.
The real issue is that CORE64 is divergent from almost all
AC literature. Almost every published study of CAC, including
,000 participant multicenter trials undergoing CAC and inva-
ive angiography, demonstrate high sensitivity (90%) and lower
pecificity (50%) (2). Sarwar et al. (3) demonstrated a sensitivity
f 98% for CAC to detect obstructive disease among 10,355
ymptomatic patients with a 56% prevalence (identical prevalence
o Gottlieb et al. [1]). Results from the first multicenter 64-slice
omputed tomography angiography (CTA) trial demonstrated
AC sensitivity of 94% and specificity 42% for 50% stenosis by
uantitative coronary angiography (4). Gottlieb et al. (1) present
he opposite results (sensitivity 45% and specificity 91%), calling
nto question study design, equipment, or CAC methodology, not
alidity of CAC testing. Hypotheses why the Gottlieb et al. (1)
tudy diverges from the CAC literature include: threshold for
AC (attenuation 130 Hounsfield units [HU], developed for
lectron beam tomography [2], not validated for Aquilion 64
Toshiba Medical Systems, Otawara, Japan]), pixel size (requiring
arger minimum area for CAC results in lower sensitivity, meth-
dology not reported in Gottlieb et al. [1]), patient selection
including acute coronary syndrome [ACS], known coronary artery
isease [CAD], and prior revascularization), or other technical
canner issues (filters, reconstruction kernels). It has been demon-
trated that different scanners have different operating character-
stics and different CAC reproducibility (5). A CAC threshold of
10 HU was suggested for multidetector computed tomography
MDCT) scanners, and this simple methodological correction may
ield more typical results (2).
Surprisingly, the authors went beyond the scope of their study
o discuss prognostic implications. CAC prognostic studies have
eported on follow-up of over 100,000 patients, clearly demon-
trating a zero score carries excellent long-term prognosis (2,3).
e followed patients for 8 years after emergency room admission,
nd patients with zero scores experienced coronary events (3), and
studies followed 3,924 symptomatic persons over 42 months,
emonstrating CAC safety and efficacy. A recent CAC study
ollowed 1,031 patients after hospitalization for chest pain (6).
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August 10, 2010:611–5ero CCS occurred in 61%, predicting both normal nuclear and
xcellent short-term outcome, reiterating high sensitivity of CAC
esting for events and obstruction.
CAC with an effective radiation dose that approximates mam-
ography remains an effective filter for low-to-moderate pre-test
robability symptomatic patients (2). The literature, with 1,000
AC publications, is clear and, with 1 exception, consistent. CAC
esting should remain a mainstay in both diagnosis and prognosis
f the cardiac patient.
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e thank the authors for their letters and for the interest in our
tudy and their thoughtful remarks. We would like to add some
omments.
As Drs. Correia and Blaha noted, the predictive values found in
ur paper (1) have slightly different meanings than commonly
tilized in other trials (2). This is so because we chose to take a
ifferent perspective. Our aim was to determine if a calcium score
CS) of 0 (positive scan for us) could predict the absence of
bstructive coronary artery disease (CAD), whereas the other trials
hey refer to examined the question of whether the presence of
alcium increases the likelihood of chest pain being related to
ignificant stenosis (2). We thank both for the opportunity to
urther clarify this issue.
Using our approach of calling a zero CS a positive scan, the
ositive predictive value refers to the ability of zero calcium to rule
ut obstructive CAD. This is in fact the same message of a
egative predictive value using the “conventional” approach. This
redictive value was low in our study: 68%. Accordingly, the
ensitivity of zero calcium to detect the absence of disease (i.e., to
ule out obstructive CAD) was also low at 45%. As Dr. Blaha toints out, when our results are interpreted from this perspective,
hey are clearly consistent with previously published studies (1,2).
We feel that our approach more accurately tests the utility of the
S when applied for this specific purpose, i.e., to rule out
bstructive disease in symptomatic patients with suspected CAD
o allow for discharge from the emergency department or to direct
utpatient investigation to other causes of chest pain.
We agree with Drs. McEvoy, Timmis, and Blaha that high-
uality research has been performed in determining the epidemi-
logic value of coronary calcium as a marker of atherosclerosis-
elated adverse events in asymptomatic individuals, and we thank
hem for stressing once again that our study did not investigate this
atient population. Our study documents the limitations of coro-
ary calcification in symptomatic individuals suspected of having
bstructive CAD. In fact, it quantifies something that experienced
linical cardiologists already know and have incorporated in their
linical practice (i.e., noncalcified plaque can rupture and cause a
yocardial infarction) and this phenomenon is not that uncom-
on, particularly among patients usually considered to be at low
isk for coronary disease (e.g., women and younger individuals) (3).
his was again confirmed in vivo in our study in which 20% of the
otally occluded vessels were free from calcification (1).
Referring to the ACCURACY (Assessment by Coronary Com-
uted Tomographic Angiography of Individuals Undergoing In-
asive Coronary Angiography) trial (4), Dr. Budoff states that it
demonstrated CAC sensitivity of 94% and specificity 42% for
50% stenosis by quantitative coronary angiography” and contin-
es by stating that “Gottlieb et al. present the opposite results
sensitivity 45% and specificity 91%), calling into question study
esign, equipment, or CAC methodology, not validity of CAC
esting.” In fact, their results are very similar to ours, just expressed
ifferently. As noted above, the ACCURACY CS sensitivity of
4% for the presence of stenosis matches our (CORE64 [Coronary
valuation Using Multi-Detector Spiral Computed Tomography
ngiography Using 64 Detectors]) CS specificity of 91% for the
bsence of stenosis, whether their specificity of 42% for the
resence of stenosis matches our sensitivity of 45% for the absence
f stenosis.
Regarding our CS methodology, we followed standard imaging
arameters and requirements recommended by the American
ollege of Cardiology/American Heart Association guidelines (5).
lthough we recognize that multidetector computed tomography
MDCT) scanners have different performance parameters as com-
ared with electron beam computed tomography (EBCT), in
linical practice, CS is more often measured with MDCT than
BCT due to the former’s much better performance in coronary
ngiography.
One could be tempted to generalize our findings to all sub-
roups of patients, mixing symptomatic and asymptomatic patients
s being the same. This is a grave mistake. Dr. Budoff states that
ur study trumps more than a 1,000 studies and that prognosis of
ero CS has been assessed in over 100,000 patients, but he
egrettably misses the fact that the vast majority of the published
S literature refers to asymptomatic patients.
Dr. Budoff questions exclusion of patients with CS600 in our
tudy. This group would, by definition, be irrelevant to our paper,
he main point of which was to demonstrate the prevalence of
ignificant disease in symptomatic patients having no coronary
alcium.
While we take the opportunity to thank Dr. Rita Redberg forhe time and effort in appraising our work and the comments on
